|
|
Raptiva warnings updated.(Complications and side effects)(Brief Article)
- Article from:
- Physician Assistants' Prescribing Reference
- Article date:
- December 22, 2005
CopyrightCOPYRIGHT 2005 Haymarket Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The labeling for the immunosuppressive agent, Raptiva (efalizumab, from Genentech) has been updated with a warning regarding events of immune-mediated hemolytic anemia associated with the use of this drug. Reports of hemolytic anemia, some serious, diagnosed 4-6 months after the start ...
Related newspaper, magazine, and journal articles:
|
|
Article: Autoimmune hemolytic anemia caused by cold ...
Journal of Maternal - Fetal & Neonatal Medicine;
April 1, 2006 ;
700+ words
...Abstract Autoimmune hemolytic anemia is a rare disorder. A 34-year old ... of gestation. Keywords: Autoimmune hemolytic anemia, cold agglutinins Introduction In autoimmune hemolytic anemia (AHA), antibodies are produced against ...
|
|